-
-
-
-
-
-
-
CorMedix (CRMD) Announces FDA Acceptance of NDA Resubmission for DefenCath
-
-
-
-
-
-
-
Truist Securities Reiterates CorMedix (CRMD) at Buy, Calls DefenCath NDA Resubmission a "Huge Relief"
-
-
-
-
-
-
-
CorMedix Appoints Greg Duncan to its Board of Directors
-
-
-
-
-
-
-
CorMedix Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
-
-
15,963 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


